Abstract
Serpins in the mammalian body are highly potent serine protease inhibitors which modulate both thrombotic and thrombolytic pathway activation, with direct and indirect crosstalk with immune and inflammatory pathways. In this review, we discuss mammalian and viral serpins as regulators of coagulation and inflammation. We focus first on the thrombotic and thrombolytic serine proteases and known interactions between these protease cascades and elements of the innate immune response. Serpin-mediated regulation of the thrombotic pathway is then discussed, with emphasis on those serpins that have been evaluated as potential new drugs. Finally the potential of viral serpins that target the coagulation and thrombolytic cascades as potential therapeutics for anti-inflammatory properties is discussed from basic molecular activity to studies in animal models. The studies discussed range from thrombosis and hemorrhage to vascular disease and transplant rejection and finally to sepsis and clinical studies in humans. In conclusion, these unique proteins, the serpin family, now have demonstrated therapeutic potential for a wide variety of inflammatory diseases in both animal and human studies and represent a new approach for drug development.
Keywords: Serpin, protease, thrombosis, thrombolysis, vascular, inflammation.
Cardiovascular & Hematological Disorders-Drug Targets
Title:The Serpin Solution; Targeting Thrombotic and Thrombolytic Serine Proteases in Inflammation
Volume: 13 Issue: 2
Author(s): Hao Chen, Jennifer A. Davids, Donghang Zheng, Marsha Bryant, Ilze Bot, Theo J.C. van Berckel, Erik Biessen, Carl Pepine, Kate Ryman, Ann Progulski-Fox, Lakshmyya Kesavalu, Richard Moyer, Grant McFadden and Alexandra Lucas
Affiliation:
Keywords: Serpin, protease, thrombosis, thrombolysis, vascular, inflammation.
Abstract: Serpins in the mammalian body are highly potent serine protease inhibitors which modulate both thrombotic and thrombolytic pathway activation, with direct and indirect crosstalk with immune and inflammatory pathways. In this review, we discuss mammalian and viral serpins as regulators of coagulation and inflammation. We focus first on the thrombotic and thrombolytic serine proteases and known interactions between these protease cascades and elements of the innate immune response. Serpin-mediated regulation of the thrombotic pathway is then discussed, with emphasis on those serpins that have been evaluated as potential new drugs. Finally the potential of viral serpins that target the coagulation and thrombolytic cascades as potential therapeutics for anti-inflammatory properties is discussed from basic molecular activity to studies in animal models. The studies discussed range from thrombosis and hemorrhage to vascular disease and transplant rejection and finally to sepsis and clinical studies in humans. In conclusion, these unique proteins, the serpin family, now have demonstrated therapeutic potential for a wide variety of inflammatory diseases in both animal and human studies and represent a new approach for drug development.
Export Options
About this article
Cite this article as:
Chen Hao, Davids A. Jennifer, Zheng Donghang, Bryant Marsha, Bot Ilze, Berckel J.C. van Theo, Biessen Erik, Pepine Carl, Ryman Kate, Progulski-Fox Ann, Kesavalu Lakshmyya, Moyer Richard, McFadden Grant and Lucas Alexandra, The Serpin Solution; Targeting Thrombotic and Thrombolytic Serine Proteases in Inflammation, Cardiovascular & Hematological Disorders-Drug Targets 2013; 13 (2) . https://dx.doi.org/10.2174/1871529X11313020003
DOI https://dx.doi.org/10.2174/1871529X11313020003 |
Print ISSN 1871-529X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4063 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting α7 Nicotinic Acetylcholine Receptor to Combat Inflammation in Cardio-Cerebral-Vascular Diseases
Current Drug Targets Association of Mean Platelet Volume with Hypertension in Rheumatoid Arthritis
Inflammation & Allergy - Drug Targets (Discontinued) The Therapeutic Potential of Cell-Internalizing Aptamers
Current Topics in Medicinal Chemistry Combinational Approaches Targeting Neurodegeneration, Oxidative Stress, and Inflammation in the Treatment of Diabetic Retinopathy
Current Drug Targets Executive Function and Diabetes Mellitus - A Stone Left Unturned?
Current Diabetes Reviews Mesenchymal Stem Cells: A Potent Cell Source for COVID-19
Coronaviruses Is There an Association between Periodontitis and Hypertension?
Current Cardiology Reviews Cranberry for Urinary Tract Infection: From Bench to Bedside
Current Topics in Medicinal Chemistry Patients with Prehypertension - Do we have Enough Evidence to Treat them?
Current Vascular Pharmacology The Effects of Prostaglandin E-1 in Patients with Intermittent Claudication
Cardiovascular & Hematological Disorders-Drug Targets Editorial: Your VISION Will Become Clear Only When You Look Into Your Heart
Current Vascular Pharmacology High Sensitivity C-Reactive Protein as a Potential Biomarker of Neuroinflammation in Major Psychiatric Disorders
Current Psychiatry Reviews The Fetal Origins of Obesity: Early Origins of Altered Food Intake
Endocrine, Metabolic & Immune Disorders - Drug Targets Acute Respiratory Failure in Obstetric Patients
Current Women`s Health Reviews The Adult Patient with Eisenmenger Syndrome: A Medical Update after Dana Point Part III: Specific Management and Surgical Aspects
Current Cardiology Reviews Dynamics of Telomere Length in Different Age Groups in a Latvian Population
Current Aging Science Health Outcomes Associated with Hormone Therapy in Australian Women
Current Drug Safety Editorial [Hot Topic: Novel Peptides and Proteins in Diabetes Mellitus (Guest Editors: Po Sing Leung and Marc de Gasparo)]
Current Protein & Peptide Science Canagliflozin : A New Hope in the Antidiabetic Armamentarium
Recent Patents on Cardiovascular Drug Discovery The Role of Nitric Oxide on Endothelial Function
Current Vascular Pharmacology